Madarosis: A Qualitative Study to Assess Perceptions and Experience of Australian Patients with Early Breast Cancer Treated with Taxane-Based Chemotherapy

    August 2017 in “ Supportive care in cancer
    Katherine E. Smith, Julie Winstanley, F. Boyle, Amanda O’Reilly, Michelle White, Yoland Antill
    TLDR Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.
    This qualitative study explored the perceptions and experiences of 25 Australian women, aged 35-64, who underwent taxane-based chemotherapy for early breast cancer and experienced madarosis (eyebrow and eyelash loss). Thematic analysis revealed seven key themes: timing of regrowth and permanent changes, the significance of eyebrows/eyelashes, preparedness and information provided, the impact of hair loss on self and others, physiological side effects, and management strategies. Participants also reported eye irritation attributed to madarosis. The study underscored the significant impact of madarosis on quality of life and highlighted the need for further research and the development of tools to measure this impact.
    Discuss this study in the Community →

    Cited in this study

    5 / 5 results